Jeff Yass’s Bright Minds Biosciences DRUG Stock Holding History

Jeff Yass’s Portfolio DRUG Stock Details DRUG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,141	Closed	-$229K	–	13619
2026 Q1	$229K	Buy	+3,141	New	+$253K	﹤0.01%	11442

Other funds holding DRUG

Jupiter Topco New York $245B AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jeff Yass's DRUG Position: Q2 2026 in Review

Jeff Yass sold out of Bright Minds Biosciences (DRUG) in Q2 2026, closing a stake of 3,141 shares — an estimated $229K sold.

Jeff Yass first reported a position in DRUG in Q1 2026 and held it in 1 quarter. The position peaked at $229K in Q1 2026. 99 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

Jeff Yass reported no remaining Bright Minds Biosciences position as of Q2 2026 after selling out during the quarter.
Jeff Yass sold 3,141 Bright Minds Biosciences shares in Q2 2026, an estimated $229K.
Jeff Yass first reported a position in Bright Minds Biosciences in Q1 2026 and held it in 1 quarter.
Jeff Yass's Bright Minds Biosciences position peaked at $229K in Q1 2026.
99 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.